CRISM Therapeutics's latest marketcap:
As of 08/02/2025, CRISM Therapeutics's market capitalization has reached $5.7 M. According to our data, CRISM Therapeutics is the 43393th most valuable company globally by market capitalization. Market capitalization, commonly referred to as market cap, represents the total market value of all outstanding shares of a publicly traded company and is often used as a measure of company value.
| Market Cap | 5.7 M |
| Revenue (ttm) | 33,195 |
| Net Income (ttm) | -805,974.6 |
| Shares Out | 39.96 M |
| EPS (ttm) | -0.03 |
| Forward PE | 0.00 |
| Ex-Dividend Date | n/a |
| Earnings Date | 09/19/2025 |
CRISM Therapeutics's yearly market capitalization.
| Date | Market Cap(£) | Market Cap(USD) | Change (%) | Global Rank |
|---|---|---|---|---|
| 08/02/2025 | £4.3 M | $5.7 M | 19.51% | 43393 |
| 12/31/2024 | £3.59 M | $4.5 M | 186.75% | 41223 |
| 09/07/2023 | £1.25 M | $1.6 M | -91% | 42089 |
| 12/30/2022 | £13.93 M | $16.84 M | -40.8% | 33546 |
| 12/31/2021 | £23.53 M | $31.8 M | 6.56% | 30256 |
| 12/31/2020 | £22.08 M | $30.18 M | 31.56% | 27492 |
| 12/31/2019 | £16.78 M | $22.25 M | -39.59% | 25957 |
| 12/31/2018 | £27.78 M | $35.42 M | -38.63% | 22778 |
| 12/29/2017 | £45.27 M | $61.11 M | -23.11% | 20517 |
| 12/30/2016 | £58.87 M | $72.69 M | 64.52% | 17495 |
Company Profile
About CRISM Therapeutics Corporation
CRISM Therapeutics Corporation specializes in innovative drug delivery technologies designed to enhance the clinical effectiveness of cancer treatments, particularly for solid tumors.
Key Product: ChemoSeed
The company's flagship product, ChemoSeed, is a breakthrough implantable drug delivery system. It can be:
- Directly implanted into a tumor
- Placed in the resection margin post-tumor removal
This targeted approach ensures high therapeutic concentrations of chemotherapy drugs reach the tumor tissue efficiently.
Primary Application
ChemoSeed is currently being developed for the treatment of gliomas, a type of aggressive brain tumor.
Company Background
Founded in 2016, CRISM Therapeutics is headquartered in Road Town, the British Virgin Islands.
Frequently Asked Questions
-
What is CRISM Therapeutics's (AIM-CRTX) current market cap?As of 08/02/2025, CRISM Therapeutics (including the parent company, if applicable) has an estimated market capitalization of $5.7 M USD. This figure represents the total market value of its outstanding shares, including different share classes. Please note that market capitalization fluctuates based on market conditions, and the actual valuation may differ from the latest estimate.
-
Where does CRISM Therapeutics (AIM-CRTX) rank globally by market cap?CRISM Therapeutics global market capitalization ranking is approximately 43393 as of 08/02/2025. This ranking is relative to all publicly traded companies worldwide and can fluctuate based on market dynamics and the performance of other companies. You can refer to our Global companies market cap ranking for the most up-to-date ranking.